Ident. | Authors (with country if any) | Title |
---|
000578 |
Asha Kishore [Canada] ; Alberto J. Espay [Canada] ; Connie Marras [Canada] ; Thamer Al-Khairalla [Canada] ; Tamara Arenovich [Canada] ; Abena Asante [Canada] ; Janis Miyasaki [Canada] ; Anthony E. Lang [Canada] | Unilateral versus bilateral tasks in early asymmetric Parkinson's disease : Differential effects on bradykinesia |
000579 |
Joseph Jankovic [États-Unis] ; Ray L. Watts [États-Unis] ; Wayne Martin [Canada] ; Babak Boroojerdi [États-Unis] | Transdermal rotigotine : Double-blind, placebo-controlled trial in parkinson disease |
000582 |
Anthony E. Lang [Canada] | The progression of Parkinson disease : A hypothesis |
000585 |
B. Ravina [États-Unis] ; R. Camicioli [Canada] ; P. G. Como [États-Unis] ; L. Marsh [États-Unis] ; Joseph Jankovic [États-Unis] ; D. Weintraub [États-Unis] ; J. Elm [États-Unis] | The impact of depressive symptoms in early Parkinson disease |
000586 |
Philippe Huot [Canada] ; Martin Levesque [Canada] ; André Parent [Canada] | The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea |
000587 |
Irene Litvan [États-Unis] ; Marie-Francoise Chesselet [États-Unis] ; Thomas Gasser [Allemagne] ; Donato A. Di Monte [États-Unis] ; Davis Jr Parker [États-Unis] ; Theo Hagg [États-Unis] ; John Hardy [États-Unis] ; Peter Jenner [Royaume-Uni] ; Richard H. Myers [États-Unis] ; Donald Price [États-Unis] ; Mark Hallett [États-Unis] ; William J. Langston [États-Unis] ; Anthony E. Lang [Canada] ; Glenda Halliday [Australie] ; Walter Rocca [États-Unis] ; Charles Duyckaerts [France] ; Dennis W. Dickson [États-Unis] ; Yoav Ben-Shlomo [Royaume-Uni] ; Christopher G. Goetz [États-Unis] ; Eldad Melamed [Israël] | The etiopathogenesis of parkinson disease and suggestions for future research. Part II |
000588 |
Irene Litvan [États-Unis] ; Glenda Halliday [Australie] ; Mark Hallett [États-Unis] ; Christopher G. Goetz [États-Unis] ; Walter Rocca [États-Unis] ; Charles Duyckaerts [France] ; Yoav Ben-Shlomo [Royaume-Uni] ; Dennis W. Dickson [États-Unis] ; Anthony E. Lang [Canada] ; Marie-Francoise Chesselet [États-Unis] ; William J. Langston [États-Unis] ; Donato A. Di Monte [États-Unis] ; Thomas Gasser [Allemagne] ; Theo Hagg [États-Unis] ; John Hardy [États-Unis] ; Peter Jenner [Royaume-Uni] ; Eldad Melamed [Israël] ; Richard H. Myers [États-Unis] ; Davis Jr Parker [États-Unis] ; Donald L. Price [États-Unis] | The etiopathogenesis of parkinson disease and suggestions for future research. Part I |
000597 |
A. Sailer [Canada, Suède] ; D. I. Cunic [Canada] ; G. O. Paradiso [Canada] ; C. A. Gunraj [Canada] ; A. Wagle-Shukla [Canada] ; E. Moro [Canada] ; A. M. Lozano [Canada] ; A. E. Lang [Canada] ; R. Chen [Canada] | Subthalamic nucleus stimulation modulates afferent inhibition in Parkinson disease |
000599 |
Penelope J. Hallett [États-Unis] ; J. M. Brotchie [Canada] | Striatal delta opioid receptor binding in experimental models of Parkinson's disease and dyskinesia |
000602 |
Peter M. Rees [Canada] ; Clare J. Fowler [Royaume-Uni] ; Cornelis P. Maas [Pays-Bas] | Sexual function in men and women with neurological disorders |
000607 |
S. Wang [Royaume-Uni] ; Y. Chen [États-Unis] ; M. Ding [États-Unis] ; J. Feng [Royaume-Uni] ; J. F. Stein [Royaume-Uni] ; T. Z. Aziz [Royaume-Uni] ; X. Liu [Royaume-Uni] | Revealing the dynamic causal interdependence between neural and muscular signals in Parkinsonian tremor |
000608 |
Ana Djarmati [Allemagne] ; Miodrag Guzvic [Allemagne, Serbie] ; Anne Grünewald [Allemagne] ; Anthony E. Lang [Canada] ; Peter P. Pramstaller [Italie] ; David K. Simon [États-Unis] ; Angela M. Kaindl [Allemagne] ; Peter Vieregge [Allemagne] ; Anders O. H. Nygren [Pays-Bas] ; Christian Beetz [Allemagne] ; Katja Hedrich [Allemagne] ; Christine Klein [Allemagne] | Rapid and reliable detection of exon rearrangements in various movement disorders genes by multiplex ligation-dependent probe amplification |
000609 |
R. L. Watts [États-Unis] ; Joseph Jankovic [États-Unis] ; C. Waters [États-Unis] ; A. Rajput [Canada] ; B. Boroojerdi [Allemagne] ; J. Rao [États-Unis] | Randomized, blind, controlled trial of transdermal rotigotine in early Parkinson disease |
000612 |
Janis M. Miyasaki [Canada] ; Khalid Al Hassan [Canada] ; Anthony E. Lang [Canada] ; Valerie Voon [Canada] | Punding prevalence in Parkinson's disease |
000613 |
YU YAO [Canada] ; Amandio Vieira [Canada] | Protective activities of Vacciniutn antioxidants with potential relevance to mitochondrial dysfunction and neurotoxicity |
000614 |
Anne M. Landau [Canada] ; Edouard Kouassi [Canada] ; Rosmarie Siegrist-Johnstone [Canada] ; Julie Desbarats [Canada] | Proteasome inhibitor model of Parkinson's disease in mice is confounded by neurotoxicity of the ethanol vehicle |
000619 |
Nikolaos Yiannakoulias [Canada] ; Donald P. Schopflocher [Canada] ; Sharon A. Warren [Canada] ; Lawrence W. Svenson [Canada] | Parkinson's disease, multiple sclerosis and changes of residence in Alberta |
000625 |
Christopher G. Goetz [États-Unis] ; Stanley Fahn [États-Unis] ; Pablo Martinez-Martin [Espagne] ; Werner Poewe [Autriche] ; Cristina Sampaio [Portugal] ; Glenn T. Stebbins [États-Unis] ; Matthew B. Stern [États-Unis] ; Barbara C. Tilley [États-Unis] ; Richard Dodel [Allemagne] ; Bruno Dubois [France] ; Robert Holloway [États-Unis] ; Joseph Jankovic [États-Unis] ; Jaime Kulisevsky [Espagne] ; Anthony E. Lang [Canada] ; Andrew Lees [Royaume-Uni] ; Sue Leurgans [États-Unis] ; Peter A. Lewitt [États-Unis] ; David Nyenhuis [États-Unis] ; C. Warren Olanow [États-Unis] ; Olivier Rascol [France] ; Anette Schrag [Royaume-Uni] ; Jeanne A. Teresi [États-Unis] ; Jacobus J. Van Hilten [Pays-Bas] ; Nancy Lapelle [États-Unis] | Movement disorder society-sponsored revision of the unified Parkinson's disease rating scale (MDS-UPDRS) : Process, format, and clinimetric testing plan |
000626 |
Alexandre Berney [Canada, Suisse] ; Michel Panisset [Canada] ; Abbas F. Sadikot [Canada] ; Alain Ptito [Canada] ; Alain Dagher [Canada] ; Maria Fraraccio [Canada] ; Ghislaine Savard [Canada] ; Marc Pell [Canada] ; Chawki Benkelfat [Canada] | Mood Stability during Acute Stimulator Challenge in Parkinson's Disease Patients Under Long-Term Treatment with Subthalamic Deep Brain Stimulation |
000629 |
Valerie Voon [États-Unis, Canada] ; Susan H. Fox [Canada] | Medication-related impulse control and repetitive behaviors in parkinson disease |
000630 |
K. V. Rama Rao [États-Unis] ; P. V. B. Reddy [États-Unis] ; A. S. Hazell [Canada] ; M. D. Norenberg [États-Unis] | Manganese induces cell swelling in cultured astrocytes |
000631 |
Richard M. Camicioli [Canada] ; Christopher C. Hanstock [Canada] ; Thomas P. Bouchard [Canada] ; Myrlene Gee [Canada] ; Nancy J. Fisher [Canada] ; W. R. Wayne Martin [Canada] | Magnetic resonance spectroscopic evidence for presupplementary motor area neuronal dysfunction in Parkinson's disease |
000634 |
Nicolas Dupre [Canada] ; Jean-Baptiste Riviere [Canada] ; Richard H. Myers [États-Unis] ; Pierre Provencher [Canada] ; Emmanuelle Pourcher [Canada] ; Francois Emond [Canada] ; Guy A. Rouleau [Canada] | Lrrk2 is not a significant cause of parkinson's disease in French-Canadians |
000637 |
D. A. Grimes [Canada] ; L. Racacho [Canada] ; F. Han [Canada] ; M. Panisset [Canada] ; D. E. Bulman [Canada] | LRRK2 screening in a Canadian Parkinson's disease cohort |
000639 |
Ronald B. Postuma [Canada] ; Christina Wolfson [Canada] ; Ali Rajput [Canada] ; A. Jon Stoessl [Canada] ; W. R. Wayne Martin [Canada] ; Oksana Suchowersky [Canada] ; Sylvain Chouinard [Canada] ; Michel Panisset [Canada] ; Mandar S. Jog [Royaume-Uni] ; David A. Grimes [Canada] ; Connie Marras [Canada] ; Anthony E. Lang [Canada] | Is there seasonal variation in risk of Parkinson's disease? |
000643 |
Jie-Yuan Li [Canada, Taïwan] ; Alberto J. Espay [Canada] ; Carolyn A. Gunraj [Canada] ; Pramod K. Pal [Canada] ; Danny I. Cunic [Canada] ; Anthony E. Lang [Canada] ; Robert Chen [Canada] | Interhemispheric and ipsilateral connections in Parkinson's disease : Relation to mirror movements |
000647 |
Ivan L. Cepeda [Canada] ; Joseph Flores [Canada] ; Michael L. Cornfeldt [États-Unis] ; John R. O'Kusky [Canada] ; Doris J. Doudet [Canada] | Human retinal pigment epithelial cell implants ameliorate motor deficits in two rat models of parkinson disease |
000650 |
Valerie Voon [États-Unis] ; Teri Thomsen [Canada] ; Janis M. Miyasaki [Canada] ; Minella De Souza [Canada] ; Ariel Shafro [Canada] ; Susan H. Fox [Canada] ; Sarah Duff-Canning [Canada] ; Anthony E. Lang [Canada] ; Mateusz Zurowski [Canada] | Factors associated with dopaminergic drug-related pathological gambling in parkinson disease |
000655 |
Quincy J. Almeida [Canada] ; James S. Frank [Canada] ; Eric A. Roy [Canada] ; Aftab E. Patla [Canada] ; Mandar S. Jog [Canada] | Dopaminergic modulation of timing control and variability in the gait of parkinson's disease |
000659 |
A. Minguez-Castellanos [Espagne] ; C. E. Chamorro [Espagne] ; F. Escamilla-Sevilla [Espagne] ; A. Ortega-Moreno [Espagne] ; A. C. Rebollo [Espagne] ; M. Gomez-Rio [Espagne] ; A. Concha [Espagne] ; D. G. Munoz [Espagne, Canada] | Do α-synuclein aggregates in autonomic plexuses predate Lewy body disorders? : A cohort study |
000663 |
Oury Monchi [Canada] ; Michael Petrides [Canada] ; Beatriz Mejia-Constain [Canada] ; Antonio P. Strafella [Canada] | Cortical activity in Parkinson's disease during executive processing depends on striatal involvement |
000664 |
Richard Camicioli [Canada] ; Serge Gauthier [Canada] | Clinical trials in Parkinson's disease dementia and dementia with lewy bodies |
000666 |
Murat Emre [Turquie] ; Dag Aarsland [Norvège] ; Richard Brown [Royaume-Uni] ; David J. Burn [Royaume-Uni] ; Charles Duyckaerts [France] ; Yoshikino Mizuno [Japon] ; Gerald Anthony Broe [Australie] ; Jeffrey Cummings [États-Unis] ; Dennis W. Dickson [États-Unis] ; Serge Gauthier [Canada] ; Jennifer Goldman [États-Unis] ; Christopher Goetz [États-Unis] ; Amos Korczyn [Israël] ; Andrew Lees [Royaume-Uni] ; Richard Levy [France] ; Irene Litvan [États-Unis] ; Ian Mckeith [Royaume-Uni] ; Warren Olanow [États-Unis] ; Werner Poewe [Autriche] ; Niall Quinn [Royaume-Uni] ; Christina Sampaio [Portugal] ; Eduardo Tolosa [Espagne] ; Bruno Dubois [France] | Clinical diagnostic criteria for dementia associated with parkinson's disease |
000668 |
Joseph Flores [Canada] ; Ivan L. Cepeda [Canada] ; Michael L. Comfeldt [États-Unis] ; John R. O'Kusky [Canada] ; Doris J. Doudet [Canada] | Characterization and survival of long-term implants of human retinal pigment epithelial cells attached to gelatin microcarriers in a model of parkinson disease |
000669 |
Manon Lebel [Canada] ; Pierre Robinson [Canada] ; Michel Cyr [Canada] | Canadian association of neurosciences review : The role of dopamine receptor function in neurodegenerative diseases |
000672 |
Hernish J. Acharya [Canada] ; Thomas P. Bouchard [Canada] ; Derek J. Emery [Canada] ; Richard M. Camicioli [Canada] | Axial signs and magnetic resonance imaging correlates in Parkinson's disease |
000673 |
XUEMEI HUANG [États-Unis] ; Yueh Z. Lee [États-Unis] ; Martin Mckeown [Canada] ; Guido Gerig [États-Unis] ; HONGBIN GU [États-Unis] ; WEILI LIN [États-Unis] ; Mechelle M. Lewis [États-Unis] ; Sutapa Ford [États-Unis] ; Alexander I. Troster [États-Unis] ; Daniel R. Weinberger [États-Unis] ; Martin Styner [États-Unis] | Asymmetrical ventricular enlargement in Parkinson's disease |
000674 |
Connie Marras [Canada] ; Alexander Kopp [Canada] ; FENG QIU [Canada] ; Anthony E. Lang [Canada] ; Kathy Sykora [Canada] ; Kenneth I. Shulman [Canada] ; Paula A. Rochon [Canada] | Antipsychotic use in older adults with parkinson's disease |
000678 |
| Deep brain stimulation for Parkinson's disease |
000679 |
R. B. Postuma [Canada] ; A. J. Espay [Canada] ; C. Zadikoff [Canada] ; O. Suchowersky [Canada] ; W. R. W. Martin [Canada] ; A.-L. Lafontaine [Canada] ; R. Ranawaya [Canada] ; R. Camicioli [Canada] ; A. E. Lang [Canada] | Vitamins and entacapone in levodopa-induced hyperhomocysteinemia : A randomized controlled study |
000680 |
James Scozzafava [Canada] ; Jennifer Takahashi [Canada] ; Wendy Johnston [Canada] ; Lakshmi Puttagunta [Canada] ; W. R. Wayne Martin [Canada] | Valvular heart disease in pergolide- treated Parkinson's disease |
000681 |
Yuri Ishida [Japon] ; Atsushi Nagai [Japon] ; Shotai Kobayashi [Japon] ; Seung U. Kim [Corée du Sud, Canada] | Upregulation of protease-activated receptor-1 in astrocytes in parkinson disease : Astrocyte-mediated neuroprotection through increased levels of glutathione peroxidase |
000683 |
Susan H. Fox [Canada] ; Anthony E. Lang [Canada] ; Jonathan M. Brotchie [Canada] | Translation of nondopaminergic treatments for levodopa-induced dyskinesia from MPTP-lesioned nonhuman primates to phase IIa clinical studies : Keys to success and roads to failure |
000684 |
David A. Grimes [Canada] ; FABIN HAN [Canada] ; Michel Panisset [Canada] ; Lemuel Racacho [Canada] ; FENGXIA XIAO [Canada] ; RUOBING ZOU [Canada] ; Kelly Westaff [Canada] ; Dennis E. Bulman [Canada] | Translated mutation in the Nurr1 gene as a cause for Parkinson's disease |
000691 |
Muhammad A. Chishti [Arabie saoudite] ; Saeed Bohlega [Arabie saoudite] ; Maqbool Ahmed [Arabie saoudite] ; Arslan Loualich [Arabie saoudite] ; Pamela Carroll [Arabie saoudite] ; Christine Sato [Canada] ; Peter St George-Hyslop [Canada] ; David Westaway [Canada] ; Ekaterina Rogaeva [Canada] | T313M PINK1 mutation in an extended highly consanguineous saudi family with early-onset parkinson disease |
000693 |
Galit Kleiner-Fisman [États-Unis] ; Jan Herzog [Allemagne] ; David N. Fisman [États-Unis] ; Filippo Tamma [Italie] ; Kelly E. Lyons [États-Unis] ; Rajesh Pahwa [États-Unis] ; Anthony E. Lang [Canada] ; Günther Deuschl [Allemagne] | Subthalamic nucleus deep brain stimulation : Summary and meta-analysis of outcomes |
000699 |
Anthony E. Lang [Canada] ; Steven Gill [Royaume-Uni] ; Nik K. Patel [Royaume-Uni] ; Andres Lozano [Canada] ; John G. Nutt [États-Unis] ; Richard Penn [États-Unis] ; David J. Brooks [Royaume-Uni] ; Gary Hotton [Royaume-Uni] ; Elena Moro [Canada] ; Peter Heywood [Canada] ; Matthew A. Brodsky [États-Unis] ; Kim Burchiel [États-Unis] ; Patrick Kelly [États-Unis] ; Arif Dalvi [États-Unis] ; Burton Scott [États-Unis] ; Mark Stacy [États-Unis] ; Dennis Turner [États-Unis] ; V. G. Frederich Wooten [États-Unis] ; William J. Elias [Canada] ; Edward R. Laws [États-Unis] ; Vijay Dhawan [États-Unis] ; A. Jon Stoessl [Canada] ; James Matcham [Royaume-Uni] ; Robert J. Coffey [États-Unis] ; Michael Traub [États-Unis] | Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease |
000700 |
V. Voon [États-Unis, Canada] ; K. Hassan [Canada] ; M. Zurowski [Canada] ; S. Duff-Canning [Canada] ; M. De Souza [Canada] ; S. Fox [Canada] ; A. E. Lang [Canada] ; J. Miyasaki [Canada] | Prospective prevalence of pathologic gambling and medication association in Parkinson disease |
000701 |
Marc Morissette [Canada] ; Mehdi Dridi [Canada] ; Frédéric Calon [Canada] ; Abdallah Hadj Tahar [Canada] ; Leonard T. Meltzer [États-Unis] ; Paul J. Bedard [Canada] ; Thérèse Di Paolo [Canada] | Prevention of levodopa-induced dyskinesias by a selective NR1A/2B N-methyl-D-aspartate receptor antagonist in Parkinsonian monkeys : Implication of preproenkephalin |
000702 |
V. Voon [États-Unis, Canada] ; K. Hassan [Canada] ; M. Zurowski [Canada] ; M. De Souza [Canada] ; T. Thomsen [Canada] ; S. Fox [Canada] ; A. E. Lang [Canada] ; J. Miyasaki [Canada] | Prevalence of repetitive and reward-seeking behaviors in Parkinson disease |
000703 |
R. Pahwa [États-Unis] ; S. A. Factor [États-Unis] ; K. E. Lyons [États-Unis] ; W. G. Ondo [États-Unis] ; G. Gronseth [États-Unis] ; H. Bronte-Stewart [États-Unis] ; M. Hallett [États-Unis] ; J. Miyasaki [Canada] ; J. Stevens [États-Unis] ; W. J. Weiner [États-Unis] | Practice Parameter:Treatment of parkinson disease with motor fluctuations and dyskinesia (an evidence-based review) : Report of the quality standards subcommittee of the american academy of neurology |
000704 |
O. Suchowersky [Canada] ; G. Gronseth [États-Unis] ; J. Perlmutter [États-Unis] ; S. Reich [États-Unis] ; T. Zesiewicz [États-Unis] ; W. J. Weiner [États-Unis] | Practice Parameter:Neuroprotective strategies and alternative therapies for Parkinson disease (an evidence-based review) : Report of the quality standards subcommittee of the american academy of neurology |
000705 |
J. M. Miyasaki [Canada] ; K. Shannon [États-Unis] ; V. Voon [États-Unis] ; B. Ravina [États-Unis] ; G. Kleiner-Fisman [États-Unis] ; K. Anderson [États-Unis] ; L. M. Shulman [États-Unis] ; G. Gronseth [États-Unis] ; W. J. Weiner [États-Unis] | Practice Parameter:Evaluation and treatment of depression, psychosis, and dementia in parkinson disease (an evidence-based review) : Report of the quality standards subcommittee of the american academy of neurology |
000706 |
O. Suchowersky [Canada] ; S. Reich [États-Unis] ; J. Perlmutter [États-Unis] ; T. Zesiewicz [États-Unis] ; G. Gronseth [États-Unis] ; W. J. Weiner [États-Unis] | Practice Parameter:Diagnosis and prognosis of new onset Parkinson disease (an evidence-based review) : Report of the quality standards subcommittee of the american academy of neurology |
000707 |
Ronald B. Postuma [Canada] ; Anthony E. Lang [Canada] ; Jessica Massicotte-Marquez [Canada] ; Jacques Montplaisir [Canada] | Potential early markers of Parkinson disease in idiopathic REM sleep behavior disorder |
000710 |
Naomi P. Visanji [Canada] ; Jordi Gomez-Ramirez [Canada] ; Tom H. Johnston [Canada] ; Donna Pires [Canada] ; Valerie Voon [Canada] ; Jonathan M. Brotchie [Canada] ; Susan H. Fox [Canada] | Pharmacological characterization of psychosis-like behavior in the MPTP-lesioned nonhuman primate model of Parkinson's disease |
000711 |
Claire Ardouin [France] ; Valerie Voon [Canada] ; Yulia Worbe [France] ; Nehman Abouazar [France] ; Virginie Czernecki [France] ; Hassan Hosseini [France] ; Antoine Pelissolo [France] ; Elena Moro [Canada] ; Eugénie Lhommee [France] ; Anthony E. Lang [Canada] ; Yves Agid [France] ; Alim-Louis Benabid [France] ; Pierre Pollak [France] ; Luc Mallet [France] ; Paul Krack [France] | Pathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulation |
000712 |
Kaveh M. Koochesfahani [Canada] ; Raul De La Fuente-Fernandez [Canada, Espagne] ; Vesna Sossi [Canada] ; Michael Schulzer [Canada] ; Lakshmi N. Yatham [Canada] ; Thomas J. Ruth [Canada] ; Stephan Blinder [Canada] ; A. Jon Stoessl [Canada] | Oral methylphenidate fails to elicit significant changes in extracellular putaminal dopamine levels in Parkinson's disease patients : Positron emission tomographic studies |
000714 |
Francesca Morgante [Canada, Italie] ; Alberto J. Espay [Canada] ; Carolyn Gunraj [Canada] ; Anthony E. Lang [Canada] ; Robert Chen [Canada] | Motor cortex plasticity in Parkinson's disease and levodopa-induced dyskinesias |
000717 |
Judith Miklossy [Canada] ; Tetsuaki Arai [Japon] ; Jian-Ping Guo [Canada] ; Andis Klegeris [Canada] ; SHENG YU [Canada] ; Edith G. Mcgeer [Canada] ; Patrick L. Mcgeer [Canada] | LRRK2 expression in normal and pathologic human brain and in human cell lines |
000718 |
JUNCHAO TONG [Canada] ; Oleh Hornykiewicz [Autriche] ; Stephen J. Kish [Canada] | Inverse relationship between brain noradrenaline level and dopamine loss in parkinson disease : A possible neuroprotective role for noradrenaline |
000720 |
Wendy R. Galpern [Canada] ; Anthony E. Lang [Canada] | Interface between tauopathies and synucleinopathies : A tale of two proteins |
000721 |
MEI SUN [États-Unis] ; Jeanne C. Latourelle [États-Unis] ; G. Frederick Wooten [États-Unis] ; Mark F. Low [États-Unis] ; Christine Klein [Allemagne] ; Holly A. Shill [États-Unis] ; Lawrence I. Golbe [États-Unis] ; Margery H. Mark [États-Unis] ; Brad A. Racette [États-Unis] ; Joel S. Perlmutter [États-Unis] ; Abbas Parsian [États-Unis] ; Mark Guttman [Canada] ; Garth Nicholson [Australie] ; GANG XU [États-Unis] ; Jemma B. Wilk [États-Unis] ; Made H. Saint-Hilaire [États-Unis] ; Anita L. Destefano [États-Unis] ; Ranjana Prakash [États-Unis] ; Sally Williamson [États-Unis] ; Oksana Suchowersky [États-Unis] ; Nancy Labelle [États-Unis] ; John H. Growdon [États-Unis] ; Carlos Singer [États-Unis] ; Ray L. Watts [États-Unis] ; Stefano Goldwurm [Italie] ; Gianni Pezzoli [Italie] ; Kenneth B. Baker [États-Unis] ; Peter P. Pramstaller [Italie] ; David J. Burn [Royaume-Uni] ; Patrick F. Chinnery [Royaume-Uni] ; Scott Sherman [États-Unis] ; Peter Vieregge [Allemagne] ; Irene Litvan [États-Unis] ; Tammy Gillis [États-Unis] ; Marcy E. Macdonald [États-Unis] ; Richard H. Myers [États-Unis] ; James F. Gusella [États-Unis] | Influence of heterozygosity for Parkin mutation on onset age in familial parkinson disease : The genepd study |
000723 |
Cindy Zadikoff [Canada] ; Ekaterina Rogaeva [Canada] ; Ana Djarmati [Allemagne] ; Christine Sato [Canada] ; Shabnam Salehi-Rad [Canada] ; Peter St. George-Hyslop [Canada] ; Christine Klein [Canada, Allemagne] ; Anthony E. Lang [Canada] | Homozygous and heterozygous PINK1 mutations : Considerations for diagnosis and care of parkinson's disease patients |
000724 |
Zoran Todorovic [Serbie] ; Eleonora Dzoljic [Serbie] ; Ivana Novakovic [Serbie] ; Dusko Mirkovic [Serbie] ; Radan Stojanovic [Serbie] ; Zorica Nesic [Serbie] ; Maja Krajinovic [Canada] ; Milica Prostran [Serbie] ; Vladimir Kostic [Serbie] | Homocysteine serum levels and MTHFR C677T genotype in patients with Parkinson's disease, with and without levodopa therapy |
000725 |
Jordi Gomez-Ramirez [Canada] ; Tom H. Johnston [Canada] ; Naomi P. Visanji [Canada] ; Susan H. Fox [Canada] ; Jonathan M. Brotchie [Canada] | Histamine H3 receptor agonists reduce L-dopa-induced chorea, but not dystonia, in the MPTP-lesioned nonhuman primate model of parkinson's disease |
000726 |
J. B. Wilk [États-Unis] ; J. E. Tobin [États-Unis] ; O. Suchowersky [Canada] ; H. A. Shill [États-Unis] ; C. Klein [Allemagne] ; G. F. Wooten [États-Unis] ; M. F. Lew [États-Unis] ; M. H. Mark [États-Unis] ; M. Guttman [Canada] ; R. L. Watts [États-Unis] ; C. Singer [États-Unis] ; J. H. Growdon [États-Unis] ; J. C. Latourelle [États-Unis] ; M. H. Saint-Hilaire [États-Unis] ; A. L. Destefano [États-Unis] ; R. Prakash [États-Unis] ; S. Williamson [États-Unis] ; C. J. Berg [États-Unis] ; M. Sun [États-Unis] ; S. Goldwurm [Italie] ; G. Pezzoli [Italie] ; B. A. Racette [États-Unis] ; J. S. Perlmutter [États-Unis] ; A. Parsian [États-Unis] ; K. B. Baker [États-Unis] ; M. L. Giroux [États-Unis] ; I. Litvan [États-Unis] ; P. P. Pramstaller [Italie] ; G. Nicholson [Australie] ; D. J. Burn [Royaume-Uni] ; P. F. Chinnery [Royaume-Uni] ; P. Vieregge [Allemagne] ; J. T. Slevin [États-Unis] ; F. Cambi [États-Unis] ; M. E. Macdonald [États-Unis] ; J. F. Gusella [États-Unis] ; R. H. Myers [États-Unis] ; L. I. Golbe [États-Unis] | Herbicide exposure modifies GSTP1 haplotype association to parkinson onset age : The GenePD study |
000729 |
Patrick S. R. Davidson [Canada] ; David Anaki [Canada] ; Jean A. Saint-Cyr [Canada] ; Tiffany W. Chow [Canada] ; Morris Moscovitch [Canada] | Exploring the recognition memory deficit in Parkinson's disease : estimates of recollection versus familiarity |
000730 |
Rodrigo Mercado [Canada] ; Constantine Constantoyannis [Canada] ; Tomasz Mandat [Canada] ; Ajit Kumar [Canada] ; Michael Schulzer [Canada] ; A. Jon Stoessl [Canada] ; Christopher R. Honey [Canada] | Expectation and the placebo effect in parkinson's disease patients with subthalamic nucleus deep brain stimulation |
000732 |
Charles Ramassamy [Canada] | Emerging role of polyphenolic compounds in the treatment of neurodegenerative diseases : A review of their intracellular targets |
000733 |
Robert E. Gross [États-Unis] ; Paul Krack [France] ; Maria C. Rodriguez-Oroz [Espagne] ; Ali R. Rezai [États-Unis] ; Alim-Louis Benabid [France] | Electrophysiological mapping for the implantation of deep brain stimulators for Parkinson's disease and tremor |
000736 |
Richard Camicioli [Canada] ; Thomas Bouchard [Canada] ; Lisa Licis [Canada] | Dual-tasks and walking fast : Relationship to extra-pyramidal signs in advanced Alzheimer disease |
000737 |
Pershia Samadi [Canada] ; Laurent Gregoire [Canada] ; Claude Rouillard [Canada] ; Paul J. Bedard [Canada] ; Thérèse Di Paolo [Canada] ; Daniel Levesque [Canada] | Docosahexaenoic acid reduces levodopa-induced dyskinesias in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine monkeys |
000738 |
Olivier Rascol [France] ; David J. Brooks [Royaume-Uni] ; Amos D. Korczyn [Israël] ; Peter P. De Deyn [Belgique] ; Carl E. Clarke [Royaume-Uni] ; Anthony E. Lang [Canada] ; Mona Abdalla [Royaume-Uni] | Development of dyskinesias in a 5-year trial of ropinirole and L-dopa |
000739 |
Andre Machado [États-Unis] ; Ali R. Rezai [États-Unis] ; Brian H. Kopell [États-Unis] ; Robert E. Gross [États-Unis] ; Ashwini D. Sharan [États-Unis] ; Alim-Louis Benabid [France] | Deep brain stimulation for Parkinson's disease : Surgical technique and perioperative management |
000740 |
Ali R. Rezai [États-Unis] ; Brian H. Kopell [États-Unis] ; Robert E. Gross [États-Unis] ; Jerrold L. Vitek [États-Unis] ; Ashwini D. Sharan [États-Unis] ; Patricia Limousin [Royaume-Uni] ; Alim-Louis Benabid [France] | Deep brain stimulation for Parkinson's disease : Surgical issues |
000741 |
Anthony E. Lang [Canada] ; Jean-Luc Houeto [France] ; Paul Krack [France] ; Cynthia Kubu [États-Unis] ; Kelly E. Lyons [États-Unis] ; Elena Moro [Canada] ; William Ondo [États-Unis] ; Rajesh Pahwa [États-Unis] ; Werner Poewe [Autriche] ; Alexander I. Tröster [États-Unis] ; Ryan Uitti [États-Unis] ; Valerie Voon [Canada, États-Unis] | Deep brain stimulation : Preoperative issues |
000743 |
Valerie Voon [Canada, États-Unis] ; Cynthia Kubu [États-Unis] ; Paul Krack [France] ; Jean-Luc Houeto [France] ; Alexander I. Tröster [États-Unis] | Deep brain stimulation : Neuropsychological and neuropsychiatric issues |
000744 |
Todd B. Sherer [États-Unis] ; Brian K. Fiske [États-Unis] ; Clive N. Svendsen [États-Unis] ; Anthony E. Lang [Canada] ; J. William Langston [États-Unis] | Crossroads in GDNF therapy for Parkinson's disease |
000748 |
Cindy Zadikoff [Canada] ; Paula Rochon [Canada] ; Anthony Lang [Canada] | Cardiac valvulopathy associated with pergolide use |
000750 |
Jens Volkmann [Allemagne] ; Elena Moro [Canada] ; Rajesh Pahwa [États-Unis] | Basic algorithms for the programming of deep brain stimulation in Parkinson's disease |
000751 |
S. Mazza [Canada] ; J. P. Soucy [Canada] ; P. Gravel [Canada] ; M. Michaud [Canada] ; R. Postuma [Canada] ; J. Massicotte-Marquez [Canada] ; A. Decary [Canada] ; J. Montplaisir [Canada] | Assessing whole brain perfusion changes in patients with REM sleep behavior disorder |
000752 |
Brian H. Kopell [États-Unis] ; Ali R. Rezai [États-Unis] ; JIN WOO CHANG [Corée du Sud] ; Jerrold L. Vitek [États-Unis] | Anatomy and physiology of the basal Ganglia : Implications for deep brain stimulation for Parkinson's disease |
000755 |
Vesna Sossi [Canada] ; Raul De La Fuente-Fernandez [Espagne] ; Michael Schulzer [Canada] ; John Adams [Canada] ; Jon Stoessl [Canada] | Age-related differences in levodopa dynamics in Parkinson's : implications for motor complications |
000758 |
J. Lewis [États-Unis] ; G. Bench [États-Unis] ; O. Myers [États-Unis] ; B. Tinner [Canada] ; W. Staines [Canada] ; E. Barr [États-Unis] ; K. K. Divine [États-Unis] ; W. Barrington [États-Unis] ; J. Karlsson [États-Unis] | Trigeminal uptake and clearance of inhaled manganese chloride in rats and mice |
000760 |
Monty A. Silverdale [Royaume-Uni] ; S. L. Nicholson [Royaume-Uni] ; A. R. Crossman [Royaume-Uni] ; J. M. Brotchie [Canada] | Topiramate reduces levodopa-induced dyskinesia in the MPTP-lesioned marmoset model of parkinson's disease |
000761 |
B. Ravina [États-Unis] ; D. Eidelberg [États-Unis] ; J. E. Ahlskog [États-Unis] ; R. L. Albin [États-Unis] ; D. J. Brooks [Royaume-Uni] ; M. Carbon [États-Unis] ; V. Dhawan [États-Unis] ; A. Feigin [États-Unis] ; S. Fahn [États-Unis] ; M. Guttman [Canada] ; K. Gwinn-Hardy [États-Unis] ; H. Mcfarland [États-Unis] ; R. Innis [États-Unis] ; R. G. Katz [États-Unis] ; K. Kieburtz [États-Unis] ; S. J. Kish [Canada] ; N. Lange [États-Unis] ; J. W. Langston [États-Unis] ; K. Marek [États-Unis] ; L. Morin [États-Unis] ; C. Moy [États-Unis] ; D. Murphy [États-Unis] ; W. H. Oertel [Allemagne] ; G. Oliver [États-Unis] ; Y. Palesch [États-Unis] ; W. Powers [États-Unis] ; J. Seibyl [États-Unis] ; K. D. Sethi [États-Unis] ; C. W. Shults [États-Unis] ; P. Sheehy [États-Unis] ; A. J. Stoessl [Canada] ; R. Holloway [États-Unis] | The role of radiotracer imaging in Parkinson disease |
000765 |
C. Marras [Canada] ; M. P. Mcdermott [États-Unis] ; P. A. Rochon [Canada] ; C. M. Tanner [États-Unis] ; G. Naglie [Canada] ; A. Rudolph [États-Unis] ; A. E. Lang [Canada] | Survival in Parkinson disease: Thirteen-year follow-up of the DATATOP cohort |
000769 |
Melisa Proulx [Canada] ; Francois P. De Courval [Canada] ; Michael A. Wiseman [Canada] ; Michel Panisset [Canada] | Salivary production in Parkinson's disease |
000770 |
Constantine Constantoyannis [Canada] ; Caglar Berk [Canada] ; Christopher R. Honey [Canada] ; Ivar Mendez [Canada] ; Robert M. Brownstone [Canada] | Reducing hardware-related complications of deep brain stimulation |
000772 |
Anthony E. Lang [Canada] ; Janis Miyasaki [Canada] ; C. Warren Olanow [Canada] ; A. Jon Stoessl [Canada] ; Oksana Suchowersky [Canada] | Progress in clinical neurosciences : A forum on the early management of Parkinson's disease |
000774 |
Andrew Nataraj [Canada] ; Ali H. Rajput [Canada] | Parkinson's disease, stroke, and related epidemiology |
000777 |
John R. Adams [Canada] ; Hinke Van Netten [Canada] ; Michael Schulzer [Canada] ; Edwin Mak [Canada] ; Jessamyn Mckenzie [Canada] ; Audrey Strongosky [États-Unis] ; Vesna Sossi [Canada] ; Thomas J. Ruth [Canada] ; Chong S. Lee [Canada] ; Matthew Farrer [États-Unis] ; Thomas Gasser [Allemagne] ; Ryan J. Uitti [États-Unis] ; Donald B. Calne [Canada] ; Zbigniew K. Wszolek [États-Unis] ; A. Jon Stoessl [Canada] | PET in LRRK2 mutations : comparison to sporadic parkinson's disease and evidence for presymptomatic compensation |
000778 |
Ash Kishore [Canada] ; Anthony E. Lang [Canada] | Normalization of voice in spasmodic dysphonia during transient global amnesia |
000779 |
Jonathan M. Brotchie [Canada] | Nondopaminergic mechanisms in levodopa-induced dyskinesia |
000781 |
F. Han [Canada] ; D. E. Bulman [Canada] ; M. Panisset [Canada] ; D. A. Grimes [Canada] | Neurofilament M gene in a french-canadian population with Parkinson's disease |
000783 |
S. F. Farmer [Royaume-Uni] ; A. J. Espay [Canada] ; J.-Y. Li [Canada] ; L. Johnston [Canada] ; R. Chen [Canada] ; A. E. Lang [Canada] | Mirror movements in parkinsonism : evaluation of a new clinical sign. Commentary |
000787 |
C. Paisan-Ruiz [États-Unis, Espagne] ; A. E. Lang [Canada] ; T. Kawarai [Canada] ; C. Sato [Canada] ; S. Salehi-Rad [Canada] ; G. K. Fisman [Canada] ; T. Al-Khairallah [Canada] ; P. St George-Hyslop [Canada] ; A. Singleton [États-Unis] ; E. Rogaeva [Canada] | LRRK2 gene in parkinson disease : Mutation analysis and case control association study |
000791 |
Mark Stacy [États-Unis] ; Annette Bowron [Royaume-Uni] ; Mark Guttman [Canada] ; Robert Hauser [États-Unis] ; Kim Hughes [Royaume-Uni] ; Jan Petter Larsen [Norvège] ; Peter Lewitt [États-Unis] ; Wolfgang Oertel [Allemagne] ; Niall Quinn [Royaume-Uni] ; Kapil Sethi [États-Unis] ; Fabrizio Stocchi [Italie] | Identification of motor and nonmotor wearing-off in Parkinson's disease : Comparison of a patient questionnaire versus a clinician assessment |
000794 |
Julie-Christine Levesque [Canada] ; André Parent [Canada] | GABAergic interneurons in human subthalamic nucleus |
000800 |
Pershia Samadi [Canada] ; Laurent Gregoire [Canada] ; Arash Rassoulpour [États-Unis] ; Paolo Guidetti [Canada] ; Emanuela Izzo [Italie] ; Robert Schwarcz [États-Unis] ; Paul J. Bedard [Canada] | Effect of kynurenine 3-hydroxylase inhibition on the dyskinetic and antiparkinsonian responses to levodopa in parkinsonian monkeys |
000802 |
Ronald B. Postuma [Canada] ; Tamara Arenovich [Canada] ; Anthony E. Lang [Canada] | Does severity of Parkinson's disease vary according to season? |
000804 |
I. G. Mckeith [Royaume-Uni] ; D. W. Dickson [États-Unis] ; J. Lowe [Royaume-Uni] ; M. Emre [Turquie] ; J. T. O'Brien [Royaume-Uni] ; H. Feldman [Canada] ; J. Cummings [États-Unis] ; J. E. Duda [États-Unis] ; C. Lippa [États-Unis] ; E. K. Perry [Royaume-Uni] ; D. Aarsland [Norvège] ; H. Arai [Japon] ; C. G. Ballard [Royaume-Uni] ; B. Boeve [États-Unis] ; D. J. Burn [Royaume-Uni] ; D. Costa [Portugal] ; T. Del Ser [Espagne] ; B. Duboi [France] ; D. Galasko [États-Unis] ; S. Gauthier [Canada] ; C. G. Goetz [États-Unis] ; E. Gomez-Tortos [Espagne] ; F. G. Halliday [Australie] ; L. A. Hansen [États-Unis] ; J. Hardy [États-Unis] ; T. Iwatsubo [Japon] ; R. N. Kalaria [Royaume-Uni] ; D. Kaufer [États-Unis] ; R. A. Kenny [Royaume-Uni] ; A. Korczyn [Israël] ; K. Kosaka ; V. M.-Y. Lee ; A. Lees ; I. Litvan ; E. Londos ; O. L. Lopez ; S. Minoshima ; Y. Mizuno ; J. A. Molina ; E. B. Mukaetova-Ladinska [Royaume-Uni] ; F. Pasquier ; R. H. Perry [Royaume-Uni] ; J. B. Schulz ; J. Q. Trojanowski ; M. Yamada | Diagnosis and management of dementia with lewy bodies : Third report of the DLB consortium |
000808 |
Katie Wiltshire [Canada] ; Sheri Foster [Canada] ; Jeffrey A. Kaye [États-Unis] ; Brent J. Small [États-Unis] ; Richard Camicioli [Canada] | Corpus callosum in neurodegenerative diseases : Findings in Parkinson's disease |
000810 |
Victor Lun [Canada] ; Nancy Pullan [Canada] ; Nancy Labelle [Canada] ; Corey Adams [Canada] ; Oksana Suchowersky [Canada] | Comparison of the effects of a self-supervised home exercise program with a physiotherapist-supervised exercise program on the motor symptoms of Parkinson's disease |
000813 |
Anne Beuter [France] ; Emilie Barbo [Canada] ; Robert Rigal [Canada] ; Pierre J. Blanchet [Canada] | Characterization of subclinical tremor in Parkinson's disease |
000814 |
A. Nagano-Saito [Japon, Canada] ; Y. Washimi [Japon] ; Y. Arahata [Japon] ; T. Kachi [Japon] ; J. P. Lerch [Canada] ; A. C. Evans [Canada] ; A. Dagher [Canada] ; K. Ito [Japon] | Cerebral atrophy and its relation to cognitive impairment in Parkinson disease |
000815 |
Deniz Kirik [Suède] ; Anders Björklund [Suède] ; Ivar Mendez [Canada] ; Rosario Sanchez-Pernaute [États-Unis] ; Oliver Cooper [États-Unis] ; Angel Vinuela [États-Unis] ; Daniela Ferrari [États-Unis] ; Lars Björklund [États-Unis] ; Alain Dagher [Canada] ; Ole Isacson [États-Unis] | Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson's disease. Commentary |
000816 |
Marguerite Wieler [Canada] ; Richard Camicioli [Canada] ; C. Allyson Jones [Canada] ; W. R. Wayne Martin [Canada] | Botulinum toxin injections do not improve freezing of gait in Parkinson disease |
000818 |
Hans-Joachim Freund [Allemagne] ; M. C. Rodriguez-Oroz [Espagne] ; J. A. Obeso [Espagne] ; A. E. Lang [Canada] ; J.-L. Houeto [France] ; P. Pollak [France] ; S. Rehncrona [France] ; J. Kulisevsky [Espagne] ; A. Albanese [Italie] ; J. Volkmann [Allemagne] ; M. I. Hariz [Royaume-Uni] ; N. P. Quinn [Royaume-Uni] ; J. D. Speelman [Pays-Bas] ; J. Guridi [Espagne] ; I. Zamarbide [Espagne] ; A. Gironell [Espagne] ; J. Molet [Espagne] ; B. Pascual-Sedano [Espagne] ; B. Pidoux [France] ; A. M. Bonnet [France] ; Yves Agid [France] ; J. Xie [France] ; A.-L. Benabid [France] ; A. M. Lozano [Canada] ; J. Saint-Cyr [Canada] ; L. Romito [Italie] ; M. F. Contarino [Italie] ; M. Scerrati [Italie] ; V. Fraix [France] ; N. Van Blercom [France] | Bilateral deep brain stimulation in Parkinson's disease : a multicentre study with 4 years follow-up. Commentary |
000819 |
S. Karamohamed [États-Unis] ; J. C. Latourelle [États-Unis] ; B. A. Racette [États-Unis] ; J. S. Perlmutter [États-Unis] ; G. F. Wooten [États-Unis] ; M. Lew [États-Unis] ; C. Klein [Allemagne] ; H. Shill [États-Unis] ; L. I. Golbe [États-Unis] ; M. H. Mark [États-Unis] ; M. Guttman [Canada] ; G. Nicholson [Australie] ; J. B. Wilk [États-Unis] ; M. Saint-Hilaire [États-Unis] ; A. L. Destefano [États-Unis] ; R. Prakash [États-Unis] ; S. Tobin [États-Unis] ; J. Williamson [États-Unis] ; O. Suchowersky [Canada] ; N. Labell [Canada] ; B. N. J. Growdon [États-Unis] ; C. Singer [États-Unis] ; R. Watts [États-Unis] ; S. Goldwurm [Italie] ; G. Pezzoli [Italie] ; K. B. Baker [États-Unis] ; M. L. Giroux [États-Unis] ; P. P. Pramstaller [Italie] ; D. J. Burn [Royaume-Uni] ; P. Chinnery [Royaume-Uni] ; S. Sherman [États-Unis] ; P. Vieregge [Allemagne] ; I. Litvan [États-Unis] ; J. F. Gusella [États-Unis] ; R. H. Myers [États-Unis] ; A. Parsian [États-Unis] | BDNF genetic variants are associated with onset age of familial Parkinson disease : GenePD Study |
000820 |
Cindy Zadikoff [Canada] ; Anthony E. Lang [Canada] | Apraxia in movement disorders |
000821 |
Richard Camicioli [Canada] ; Ali Rajput [Canada] ; Michelle Rajput [Canada] ; Christian Reece [Canada] ; Haydeh Payami [États-Unis] ; CHUNHAI HAO [Canada] ; Alex Rajput [Canada] | Apolipoprotein E ε4 and catechol-O-methyltransferase alleles in autopsy-proven Parkinson's disease : Relationship to dementia and hallucinations |
000825 |
Samer Karamohamed [États-Unis] ; L. I. Golbe [États-Unis] ; M. H. Mark [États-Unis] ; A. M. Lazzarini [États-Unis] ; O. Suchowersky [Canada] ; N. Labelle [Canada] ; Mark Guttman [Canada] ; L. J. Currie [États-Unis] ; G. F. Wooten [États-Unis] ; M. Stacy [États-Unis] ; M. Saint-Hilaire [États-Unis] ; R. G. Feldman [États-Unis] ; J. Liu [États-Unis] ; C. M. Shoemaker [États-Unis] ; J. B. Wilk [États-Unis] ; A. L. Destefano [États-Unis] ; J. C. Latourelle [États-Unis] ; G. Xu [États-Unis] ; R. Watts [États-Unis] ; J. Growdon [États-Unis] ; M. Lew [États-Unis] ; C. Waters [États-Unis] ; P. Vieregge [Allemagne] ; P. P. Pramstaller [Italie] ; C. Klein [Allemagne] ; B. A. Racette [États-Unis] ; J. S. Perlmutter [États-Unis] ; A. Parsian [États-Unis] ; Carlos Singer [États-Unis] ; E. Montgomery [États-Unis] ; K. Baker [États-Unis] ; J. F. Gusella [États-Unis] ; A. Herbert [États-Unis] ; R. H. Myers [États-Unis] | Absence of previously reported variants in the SCNA (G88c and G209A), NR4A2 (T291D and T245G) and the DJ-1 (T497C) genes in familial parkinson's disease from the GenePD study |
000828 |
Anna Moszczynska [Canada] ; Paul Fitzmaurice [Canada] ; Lee Ang [Canada] ; Kathryn S. Kalasinsky [États-Unis] ; Gregory A. Schmunk [États-Unis] ; Frank J. Peretti [États-Unis] ; Sally S. Aiken [États-Unis] ; Dennis J. Wickham [États-Unis] ; Stephen J. Kish [Canada] | Why is parkinsonism not a feature of human methamphetamine users? |
000841 |
K. Dujardin [France] ; S. Blairy [Belgique] ; L. Defebvre [France] ; P. Krystkowiak [France] ; U. Hess [Canada] ; S. Blond [France] ; A. Destee [France] | Subthalamic nucleus stimulation induces deficits in decoding emotional facial expressions in Parkinson's disease |
000846 |
Judit Horvath [Suisse] ; Robin D. Fross [États-Unis] ; Galit Kleiner-Fisman [Canada] ; René Lerch [Suisse] ; Hans Stalder [Suisse] ; Suzanne Liaudat [Suisse] ; William J. Raskoff [États-Unis] ; Keith D. Flachsbart [États-Unis] ; Harry Rakowski [Canada] ; Jean-Claude Pache [Suisse] ; Pierre R. Burkhard [Suisse] ; Anthony E. Lang [Canada] | Severe multivalvular heart disease: A new complication of the ergot derivative dopamine agonists |
000849 |
Connie Marras [Canada] ; Anthony Lang [Canada] ; Murray Krahn [Canada] ; George Tomlinson [Canada] ; Gary Naglie [Canada] | Quality of life in early Parkinson's disease: Impact of dyskinesias and motor fluctuations |
000851 |
Sarah Furtado [Canada] ; Haydeh Payami [États-Unis] ; Paul J. Lockhart [États-Unis] ; Melissa Hanson [États-Unis] ; John G. Nutt [États-Unis] ; Andrew A. Singleton [États-Unis] ; Amanda Singleton [États-Unis] ; Jamel Bower [États-Unis] ; Ryan J. Utti [États-Unis] ; Thomas D. Bird [États-Unis] ; Raul De La Fuente-Fernandez [Canada] ; Yoshio Tsuboi [États-Unis] ; Mary L. Klimek [Canada] ; Oksana Suchowersky [Canada] ; John Hardy [États-Unis] ; Donald B. Calne [Canada] ; Zbigniew K. Wszolek [États-Unis] ; Matthew Farrer [États-Unis] ; Katrina Gwinn-Hardy [États-Unis] ; A. Jon Stoessl [Canada] | Profile of families with Parkinsonism-predominant spinocerebellar ataxia type 2 (SCA2) |
000852 |
Raul De La Fuente-Fernandez [Canada, Espagne] ; Michael Schulzer [Canada] ; Edwin Mak [Canada] ; Donald B. Calne [Canada] ; A. Jon Stoessl [Canada] | Presynaptic mechanisms of motor fluctuations in Parkinson's disease: a probabilistic model |
000854 |
Ajmal Razmy [Canada] ; Anthony E. Lang [Canada] ; Colin M. Shapiro [Canada] | Predictors of impaired daytime sleep and wakefulness in patients with Parkinson disease treated with older (ergot) vs newer (nonergot) dopamine agonists |
000856 |
M. G. Carpenter [Suisse, Canada] ; J. H. J. Allum [Suisse] ; F. Honegger [Suisse] ; A. L. Adkin [Suisse, Canada] ; B. R. Bloem [Pays-Bas] | Postural abnormalities to multidirectional stance perturbations in Parkinson's disease |
000859 |
Richard Camicioli [Canada] ; Nancy Fisher [Canada] | Parkinson's disease with dementia and dementia with Lewy bodies |
000860 |
S. Mccarthy [Canada] ; M. Somayajulu [Canada] ; M. Sikorska [Canada] ; H. Borowy-Borowski [Canada] ; S. Pandey [Canada] | Paraquat induces oxidative stress and neuronal cell death; neuroprotection by water-soluble Coenzyme Q10 |
000865 |
Richard Camicioli [Canada] ; Lisa Licis [Canada] | Motor impairment predicts falls in specialized Alzheimer care units |
000867 |
Martin Zonenshayn [États-Unis] ; Djordje Sterio [États-Unis] ; Patrick J. Kelly [États-Unis] ; Ali R. Rezai [États-Unis] ; Aleksander Beric [États-Unis] ; Kim J. Burchiel [États-Unis] ; Ronald R. Tasker [Canada] | Location of the active contact within the subthalamic nucleus (STN) in the treatment of idiopathic Parkinson's disease. Commentary |
000868 |
Raul De La Fuente-Fernandez [Canada] ; Vesna Sossi [Canada] ; ZHIGAO HUANG [Canada] ; Sarah Furtado [Canada] ; Jian-Qiang Lu [Canada] ; Donald B. Calne [Canada] ; Thomas J. Ruth [Canada] ; A. Jon Stoessl [Canada] | Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: implications for dyskinesias |
000869 |
C. Warren Olanow [États-Unis] ; Yves Agid [France] ; Yoshi Mizuno [Japon] ; Alberto Albanese [Italie] ; U. Bonucelli [Italie] ; Philip Damier [France] ; Justo De Yebenes [Espagne] ; Oscar Gershanik [Argentine] ; Mark Guttman [Canada] ; F. Grandas [Espagne] ; Mark Hallett [États-Unis] ; Ole Hornykiewicz [Autriche] ; Peter Jenner [Royaume-Uni] ; R. Katzenschlager [Royaume-Uni] ; William J. Langston [États-Unis] ; Peter Lewitt [États-Unis] ; Eldad Melamed [Israël] ; M. A. Mena [Espagne] ; P. P. Michel [France] ; Catherine Mytilineou [États-Unis] ; Jose A. Obeso [Espagne] ; Werner Poewe [Autriche] ; Niall Quinn [Royaume-Uni] ; R. Raisman-Vozari [France] ; Ali H. Rajput [Canada] ; Olivier Rascol [France] ; Christina Sampaio ; Fabrizio Stocchi | Levodopa in the treatment of Parkinson's disease: Current controversies |
000870 |
Y. Kumakura [Danemark] ; E. H. Danielsen [Danemark] ; A. Reilhac [Canada] ; A. Gjedde [Danemark, Canada] ; P. Cumming [Danemark] | Levodopa effect on [18F]fluorodopa influx to brain: normal volunteers and patients with Parkinson's disease |
000872 |
Chong S. Lee [Canada] ; Michael Schulzer [Canada] ; Raul De La Fuente-Fernandez [Canada] ; Edwin Mak [Canada] ; Lisa Kuramoto [Canada] ; Vesna Sossi [Canada] ; Thomas J. Ruth [Canada] ; Donald B. Calne [Canada] ; A. Jon Stoessl [Canada] | Lack of Regional selectivity during the progression of Parkinson disease: Implications for pathogenesis |
000873 |
Frédéric Calon [Canada] ; Mehdi Dridi [Canada] ; Oleh Hornykiewicz [Canada, Autriche] ; Paul J. Bedard [Canada] ; Ali H. Rajput [Canada] ; Thérèse Di Paolo [Canada] | Increased adenosine A2A receptors in the brain of Parkinson's disease patients with dyskinesias |
000874 |
Ronald B. Postuma [Canada] ; Anthony E. Lang [Canada] | Homocysteine and levodopa: Should Parkinson disease patients receive preventative therapy? |
000875 |
Mark D. Berry [Canada] | Glyceraldehyde-3-phosphate dehydrogenase as a target for small-molecule disease-modifying therapies in human neurodegenerative disorders |
000876 |
Huw R. Morris [Royaume-Uni] ; John C. Steele ; Richard Crook [États-Unis] ; Fabienne Wavrant-De Vrieze [États-Unis] ; Luisa Onstead-Cardinale [États-Unis] ; Katrina Gwinn-Hardy [États-Unis] ; Nick W. Wood [Royaume-Uni] ; Matthew Farrer [États-Unis] ; Andrew J. Lees [Royaume-Uni] ; P. L. Mcgeer [Canada] ; Teepu Siddique [États-Unis] ; John Hardy [Royaume-Uni, États-Unis] ; Jordi Perez-Tur [États-Unis, Espagne] | Genome-wide analysis of the Parkinsonism-dementia complex of Guam |
000880 |
R. P. Munhoz [Canada] ; J.-Y. Li [Canada] ; M. Kurtinecz [Canada] ; P. Piboolnurak [États-Unis] ; A. Constantino [États-Unis] ; S. Fahn [États-Unis] ; A. E. Lang [Canada] | Evaluation of the pull test technique in assessing postural instability in Parkinson's disease |
000881 |
Alexander Rajput [Canada] ; Christopher A. Robinson [Canada] ; Ali H. Rajput [Canada] | Essential tremor course and disability: A clinicopathologic study of 20 cases |
000882 |
S. Kedia [États-Unis] ; E. Moro [Canada] ; M. Tagliati [États-Unis] ; A. E. Lang [Canada] ; R. Kumar [États-Unis] | Emergence of restless legs syndrome during subthalamic stimulation for Parkinson disease |
000883 |
Constantine Constantoyannis [Canada] ; Brett Heilbron [Canada] ; Christopher R. Honey [Canada] | Electrocardiogram artifacts caused by deep brain stimulation |
000887 |
Katja Hedrich [Allemagne, Italie, États-Unis] ; Cordula Eskelson [Allemagne] ; Beth Wilmot [États-Unis] ; Karen Marder [États-Unis] ; Juliette Harris [États-Unis] ; Jennifer Garrels [Allemagne] ; Helen Meija-Santana [États-Unis] ; Peter Vieregge [Allemagne] ; Helfried Jacobs [Allemagne] ; Susan B. Bressman [États-Unis] ; Anthony E. Lang [Canada] ; Martin Kann [Allemagne] ; Giovanni Abbruzzese [Italie] ; Paolo Martinelli [Italie] ; Eberhard Schwinger [Allemagne] ; Laurie J. Ozelius [États-Unis] ; Peter P. Pramstaller ; Christine Klein [Allemagne] ; Patricia Kramer | Distribution, type, and origin of Parkin mutations: Review and case studies |
000888 |
Eugene Tunik [États-Unis] ; Sergei V. Adamovich [États-Unis] ; Howard Poizner [États-Unis] ; Anatol G. Feldman [Canada] | Deficits in rapid adjustments of movements according to task constraints in Parkinson's disease |
000891 |
K. Hedrich [Allemagne] ; A. Djarmati [Allemagne, Serbie] ; N. Sch Fer [Allemagne] ; R. Hering [Allemagne] ; C. Wellenbrock [Allemagne] ; P. H. Weiss [Allemagne] ; R. Hilker [Allemagne] ; P. Vieregge [Allemagne] ; L. J. Ozelius [États-Unis] ; P. Heutink [Pays-Bas] ; V. Bonifati [Pays-Bas, Italie] ; E. Schwinger [Allemagne] ; A. E. Lang [Canada] ; J. Noth [Allemagne] ; S. B. Bressman [États-Unis] ; P. P. Pramstaller [Italie] ; O. Riess [Allemagne] ; C. Klein [Allemagne] | DJ-1 (PARK7) mutations are less frequent than Parkin (PARK2) mutations in early-onset Parkinson disease |
000892 |
Ajit Kumar [Canada] ; Susan M. Calne [Canada] ; Michael Schulzer [Canada] ; Edwin Mak [Canada] ; Zbigniew Wszolek [États-Unis] ; Chris Van Netten [Canada] ; Joseph K. C. Tsui [Canada] ; A. Jon Stoessl [Canada] ; Donald B. Calne [Canada] | Clustering of Parkinson disease: Shared cause or coincidence? |
000893 |
Vesna Sossi [Canada] ; Raul De La Fuente-Fernandez [Canada] ; James E. Holden [Canada] ; Michael Schulzer [Canada] ; Thomas J. Ruth [États-Unis] ; Jon Stoessl [Canada] | Changes of dopamine turnover in the progression of Parkinson's disease as measured by positron emission tomography: Their relation to disease-compensatory mechanisms |
000895 |
Kerry B. Goralski [Canada] ; Kenneth W. Renton [Canada] | Brain inflammation enhances 1-methyl-4-phenylpyridinium-evoked neurotoxicity in rats |
000896 |
Junchao Tong [Canada] ; Paul S. Fitzmaurice [Canada] ; Lee Cyn Ang [Royaume-Uni] ; Yoshiaki Furukawa [Canada] ; Mark Gunman [Canada] ; Stephen J. Kish [Canada] | Brain dopamine-stimulated adenylyl cyclase activity in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy |
000897 |
Z. K. Wszolek [États-Unis] ; R. F. Pfeiffer [États-Unis] ; Y. Tsuboi [États-Unis] ; R. J. Uitti [États-Unis] ; R. D. Mccomb [États-Unis] ; A. J. Stoessl [Canada] ; A. J. Strongosky [États-Unis] ; A. Zimprich [Allemagne] ; B. Müller-Myhsok [Allemagne] ; M. J. Farrer [États-Unis] ; T. Gasser [Allemagne] ; D. B. Calne [Canada] ; D. W. Dickson [États-Unis] | Autosomal dominant parkinsonism associated with variable synuclein and tau pathology |
000898 |
J.-F. Gagnon [Canada] ; M. L. Fantini [Canada] ; M.-A. Bedard [Canada] ; D. Petit [Canada] ; J. Carrier [Canada] ; S. Rompre [Canada] ; A. Decary [Canada] ; M. Panisset [Canada] ; J. Montplaisir [Canada] | Association between waking EEG slowing and REM sleep behavior disorder in PD without dementia |
000899 |
Cory Toth [Canada] ; Michelle Rajput [Canada] ; Ali H. Rajput [Canada] | Anomalies of asymmetry of clinical signs in parkinsonism |
000900 |
Christine Sato [Canada] ; Angharad Morgan [Canada] ; Anthony E. Lang [Canada] ; Shabnam Salehi-Rad [Canada] ; Toshitaka Kawarai [Canada] ; YAN MENG [États-Unis] ; Peter N. Ray [Canada] ; Lindsay A. Farrer [États-Unis] ; Peter St George-Hyslop [Canada] ; Ekaterina Rogaeva [Canada] | Analysis of the glucocerebrosidase gene in Parkinson's disease |
000901 |
Ekaterina Rogaeva [Canada] ; Janel Johnson [États-Unis] ; Anthony E. Lang [Canada] ; Cindy Gulick [États-Unis] ; Katrina Gwinn-Hardy [États-Unis] ; Toshitaka Kawarai [Canada] ; Christine Sato [Canada] ; Angharad Morgan [Canada] ; John Werner [États-Unis] ; Robert Nussbaum [États-Unis] ; Agnes Petit [Canada] ; Michael S. Okun [États-Unis] ; Aideen Mcinerney [États-Unis] ; Ronald Mandel [États-Unis] ; Justus L. Groen [Canada] ; Hubert H. Fernandez [États-Unis] ; Ron Postuma [Canada] ; Kelly D. Foote [États-Unis] ; Shabnam Salehi-Rad [Canada] ; YAN LIANG [Canada] ; Sharon Reimsnider [États-Unis] ; Anurag Tandon [Canada] ; John Hardy [États-Unis] ; Peter St George-Hyslop [Canada] ; Andrew B. Singleton [États-Unis] | Analysis of the PINK1 gene in a large cohort of cases with Parkinson disease |
000903 |
Ajit Kumar [Canada] ; Sharanpal Mann [Canada] ; Vesna Sossi [Canada] ; Thomas J. Ruth [Canada] ; A. Jon Stoessl [Canada] ; Michael Schulzer [Canada] ; Chong S. Lee [Canada] | [11C]DTBZ-PET correlates of levodopa responses in asymmetric Parkinson's disease |
000914 |
Antonio P. Strafella [Canada] ; Tomas Paus [Canada] ; Maria Fraraccio [Canada] ; Alain Dagher [Canada] | Striatal dopamine release induced by repetitive transcranial magnetic stimulation of the human motor cortex |
000938 |
Jackalina Van Kampen [Canada] ; Harold Robertson [Canada] ; Theo Hagg [Canada] ; Robert Drobitch [Canada] | Neuroprotective actions of the ginseng extract G115 in two rodent models of Parkinson's disease |
000975 |
D. J. Brooks [Royaume-Uni] ; K. A. Frey [États-Unis] ; K. L. Marek [États-Unis] ; D. Cakes [États-Unis] ; D. Paty [Canada] ; R. Prentice [États-Unis] ; C. W. Shults [États-Unis] ; A. J. Stoessl [Canada] | Assessment of neuroimaging techniques as biomarkers of the progression of Parkinson's disease |
000C23 |
M. C. Evans [États-Unis] ; A. Pradhan [Canada] ; S. Venkatraman [États-Unis] ; W. H. Ojala [États-Unis] ; W. B. Gleason [États-Unis] ; R. K. Mishra [Canada] ; R. L. Johnson [États-Unis] | Synthesis and dopamine receptor modulating activity of novel peptidomimetics of L-prolyl-L-leucyl-glycinamide featuring α, α-disubstituted amino acids |
000C76 |
V. Radhakrishnan [Canada] ; J. Tsoukatos [Canada] ; K. D. Davis [Canada] ; R. R. Tasker [Canada] ; A. M. Lozano [Canada] ; J. O. Dostrovsky [Canada] | A comparison of the burst activity of lateral thalamic neurons in chronic pain and non-pain patients |
000C83 |
E. G. Mcgeer [Canada] ; P. L. Mcgeer [Canada] | The future use of complement inhibitors for the treatment of neurological diseases |
000E50 |
A. E. Lang [Canada] ; P. Sandor ; J. Duff [Canada] | Remoxipride in Parkinson's disease : differential response in patients with dyskinesias fluctuations versus psychosis |
000E80 |
R. Kanthan [Canada] ; A. Shuaib ; G. Goplen ; H. Miyashita | A new method of in-vivo microdialysis of the human brain |
000F40 |
A. Beuter [Canada] ; J. Belair ; C. Labrie | Feedback and delays in neurological diseases: a modeling study using dynamical systems |
000F63 |
A. Beuter [Canada] ; L. Carriere ; B. Mcfayden ; S. Gauthier | The organization of stepping in patients with Parkinson's disease : bradykinesia or discoordination ? |
000F64 |
D. B. Calne [Canada] | The nature of Pakinson's disease |
000F67 |
J. Starkes [Canada] ; C. Riach ; B. Clarke | The effect of eye closure on postural sway : converging evidence from children and a Parkinson patient |
000F70 |
H. A. Robertson [Canada] ; M. R. Peterson ; G. G. Worth | Synergistic and persistent interaction between the D2 agonist, bromocriptine, and the D1 selective agonist, CY 208-243 |
000F79 |
A. Tabatabaei [Canada] ; T. L. Perry ; S. Hansen ; C. Krieger | Partial protective effect of MK-4801 on MPTP-induced reduction of striatal dopamine in mice |
000F80 |
K. M. Semchuk [Canada] ; E. J. Love ; R. G. Lee | Parkinson's disease and exposure to agricultural work and pesticide chemicals |
000F85 |
B. Lavoie [Canada] ; P.-Y. Cote ; A. Parent | Immunohistochemical study of the basal ganglia in normal and Parkinsonian monkeys |
000F90 |
S. Pare [Canada] ; S. I. Barr ; S. E. Ross | Effect of daytime protein restriction on nutrient intakes of free-living Parkinson's disease patients |
000F93 |
M. Guttman [Canada] | Dopamine receptors in Parkinson's disease |
000F94 |
M. S. Pollanen [Canada] ; C. Bergeron ; L. Weyer | Detergent-insoluble cortical lewy body fibrils share epitopes with neurofilament and τ |
000F95 |
J. L. Cummings [Canada] | Depression and Parkinson's disease : a review |
000F98 |
D. B. Calne [Canada] ; B. J. Snow ; C. Lee | Criteria for diagnosing Parkinson's disease |
000F99 |
I. Aubert [Canada] ; D. M. Araujo ; D. Cecyre ; Y. Robitaille ; S. Gauthier ; R. Quirion | Comparative alterations of nicotinic and muscarinic binding sites in Alzheimer's and Parkinson's diseases |
001007 |
S. J. Kish [Canada] ; K. Shannak ; A. Rajput ; J. H. N. Deck ; O. Hornykiewicz | Aging produces a specific pattern of striatal dopamine loss : implications for the etiology of idopathic Parkinson's disease |
001008 |
A. J. Flint [Canada] ; S. E. Black ; I. Campbell-Taylor ; G. F. Gailey ; C. Levinton | Acoustic analysis in the differentiation of Parkinson's disease and major depression |
001011 |
S. Bagley [Canada] ; B. Kelly ; N. Tunnicliffe ; G. I. Turnbull ; J. M. Walker | The effect of visual cues on the gait of independently mobile Parkinson's disease patients |
001012 |
H. B. Niznik ; E. F. Fogel ; F. F. Fassos ; P. Seeman | The dopamine transporter is absent in parkinsonian putamen and reduced in the caudate nucleus |
001013 |
R. Rivest ; S. St-Pierre ; F. B. Jolicoeur | Structure-activity studies of neurotensin on muscular rigidity and tremors induced by 6-hydroxydopamine lesions in the posterolateral hypothalamus of the rat |
001015 |
W. G. Tatton [Canada] ; C. E. Greenwood | Rescue of dying neurons : a new action for deprenyl in MPTP parkinsonism |
001017 |
M. H. Bhatt ; B. J. Snow ; W. R. Wayne Martin ; B. D. Pate ; D. B. Calne | Positron emission tomography suggests that the rate of progression of idiopthic parkinsonism is slow |
001018 |
K. M. Semchuk [Canada] ; E. J. Love ; R. G. Lee | Parkinson's disease and exposure to rural environmental factors : a population based case-control study |
001019 |
J. A. Jesberger ; J. S. Richardson | Oxygen free radicals and brain dysfunction |
001020 |
A. H. Rajput [Canada] ; B. Rozdilsky ; L. Ang | Occurrence of resting tremor in Parkinson's disease |
001021 |
D. B. Calne [Canada] | Neurotoxins and degeneration in the central nervous system |
001026 |
F. B. Jolicoeur [Canada] ; R. Rivest ; A. Drumheller | Hypokinesia, rigidity, and tremor induced by hypothalamic 6-OHDA lesions in the rat |
001029 |
M. Filion ; L. Tremblay ; P. J. Bedard | Effects of dopamine agonists on the spontaneous activity of globus pallidus neurons in monkeys with MPTP-induced parkinsonism |
001030 |
B. Gomez-Mancilla [Canada] ; R. Boucher ; P. J. Bedard | Effect of clonidine and atropine on rest tremor in the MPTP monkey model of parkinsonism |
001031 |
B. Gomez-Mancilla [Canada] ; P. J. Bedard | Effect of D1 and D2 agonists and antagonists on dyskinesia produced by L-DOPA in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys |
001033 |
D. B. Calne ; M. J. Zigmond | Compensatory mechanisms in degenerative neurologic diseases : insights from Parkinsonism |
001034 |
A. H. Rajput [Canada] ; B. Rozdilsky ; L. Ang ; A. Rajput | Clinicopathologic observations in essential tremor : report of six cases |
001037 |
F. B. Jolicoeur ; R. Rivest ; S. St.-Pierre ; A. Drumheller | Antiparkinson-like effects of neurotensin in 6-hydroxydopamine lesioned rats |
001038 |
E. Keller [Canada] ; P. Vigneux ; M. Laframboise | Acoustic analysis of neurologically impaired speech |
001039 |
A. H. Rajput [Canada] ; B. Rozdilsky ; A. Rajput | Accuracy of clinical diagnosis in Parkinsonism―A prospective study |
001040 |
M. Filion ; L. Tremblay | Abnormal spontaneous activity of globus pallidus neurons in monkeys with MPTP-induced parkinsonism |
001041 |
J. Zayed ; P. Andre ; J. C. Panisset ; S. Ducic ; G. Campanella ; M. Roy ; G. Kennedy ; C. Delisle | Contamination environnementale par les métaux et maladie de Parkinson |
001042 |
A. J. Lewis ; M. J. Gawel | diffuse lewy body disease with dementia and oculomotor dysfunction |
001043 |
S. J. Kish ; L. M. Distefano ; S. Dozic ; Y. Robitaille ; A. Rajput ; J. H. N. Deck ; O. Hornykiewicz | [3H]vesamicol binding in human brain cholinergic deficiency disorders |
001048 |
N. R. C. Campbell ; D. Rankine ; A. E. Goodridge ; B. B. Hasinoff ; M. Kara | Sinemet-ferrous sulphate interaction in patients with Parkinson's disease |
001050 |
M. H. Bhatt ; B. J. Snow ; W. R. W. Martin ; S. Cooper ; D. B. Calne | Positron emission tomography in Shy-Drager syndrome |
001051 |
B. J. Snow ; R. F. Peppard ; M. Guttman ; J. Okada ; W. Martin ; J. Steele ; A. Eisen ; G. Carr ; B. Schoenberg ; D. Calne | Positron emission tomographic scanning demonstrates a presynaptic dopaminergic lesion in lytico-bodig : the amyotrophic lateral sclerosis-Parkinsonism-dementia complex of guam |
001053 |
M. Freedman | Object alternation and orbitofrontal system dysfunction in Alzheimer's and Parkinson's disease |
001054 |
D. Pare ; R. Curro'Dossi ; M. Steriade | Neuronal basis of the Parkinsonian resting tremor : a hypothesis and its implications for treatment |
001056 |
A. E. Taylor ; J. A. Saint-Cyr ; A. E. Lang | Memory and learning in early Parkinson's disease : evidence for a frontal lobe syndrome |
001058 |
M. Guttman ; H. C. Fibiger ; A. Jakubovic ; D. B. Calne | Intracarotid 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration: biochemical and behavioral observations in a primate model of hemiparkinsonism |
001059 |
A. J. Hudson ; G. P. A. Rice | Hipothesis : similitaries of guamanian ALS/PD to post-encephalitic Parkinsonism/ALS : possible viral cause |
001060 |
R. Turcotte ; C. Godin ; R. Duchesne ; A. Jodoin | Hip fractures and Parkinson's disease : a clinical review of 94 fractures treated surgically |
001061 |
L. W. Svenson | Geographic distribution of deaths due to Parkinson's disease in Canada : 1979-1986 |
001062 |
J. Zayed ; S. Ducic ; G. Companella ; J. C. Panisset ; P. Andre ; H. Masson ; M. Roy | Facteurs environnementaux dans l'étiologie de la maladie de Parkinson |
001063 |
C. Rouillard ; P. J. Bedard ; T. Di Paolo | Effects of chronic treatment of MPTP monkeys with bromocriptine alone or in combination with SKF 38393 |
001064 |
C. Gagnon ; P. J. Bedard ; T. Di Paolo | Effect of chronic treatment of MPTP monkeys with dopamine D-1 and/or D-2 receptor agonists |
001065 |
R. T. Ross | Drug-induced Parkinsonism and other movement disorders |
001067 |
P. Seeman ; H. B. Niznik | Dopamine receptors and transporters in Parkinson's disease and schizophrenia |
001068 |
T. L. Perry ; J. M. Wright ; K. Berry ; S. Hansen ; T. L. Jr Perry | Dominantly inherited apathy, central hypoventilation, and Parkinson's syndrome : clinical, biochemical, and neuropathologic studies of 2 new cases |
001070 |
J. K. C. Tsui ; R. F. Peppard ; K. C. Petruk ; G. Allen ; R. S. Burns ; D. B. Calne | Decreased efficay of levodopa with carbidopa in parkinsonian patients after adrenal-to-caudate implants |
001071 |
C. Harnois ; T. Di Paolo | Decreased dopamine in the retinas of patients with Parkinson's disease |
001072 |
R. F. Peppard ; W. R. W. Martin ; C. M. Clark ; G. D. Carr ; P. L. Mcgeer ; D. B. Calne | Cortical glucose metabolism in Parkinson's and Alzheimer's disease |
001073 |
T. Yamada ; H. Akiyama ; P. L. Mcgeer | Complement-activated oligodendroglia : a new pathogenic entity identified by immunostaining with antibodies to human complement proteins C3d and C4d |
001074 |
E. C. Wolters ; T. A. Hurwitz ; E. Mak ; P. Teal ; F. R. Peppard ; R. Remick ; S. Calne ; D. B. Calne | Clozapine in the treatment of parkinsonian patients with dopaminomimetic psychosis |
001075 |
A. E. Lang ; D. E. Riley ; L. Vachon ; X. Lataste | CQA 206-291 in Parkinson's disease : an acute single escalating dosage study |
001077 |
A. W. R. Jones ; J. S. Richardson | Alzheimer's disease : clinical and pathological characteristics |
001078 |
D. B. Calne | Is «Parkinson's disease» one disease? |
001079 |
T. L. Perry ; C. Bergeron ; A. J. Biro ; S. Hansen | β-N-methylamino-L-alanine: chronic oral administration is not neurotoxic to mice |
001081 |
VOON WEE YONG ; M. Guttman ; S. U. Kim ; D. B. Calne ; I. Turnbull ; K. Watabe ; R. W. W. Tomlinson | Transplantation of human sympathetic neurons and adrenal chromaffin cells into parkinsonian monkeys: no reversal of clinical symptoms |
001082 |
J. K. Tsui ; S. Ross ; K. Poulin ; J. Douglas ; D. Postnikoff ; S. Calne ; W. Woodward ; D. B. Calne | The effect of dietary protein on the efficacy of L-dopa: a double-blind study |
001083 |
M. Freedman ; M. Oscar-Berman | Spatial and visual learning deficits in Alzheimer's and Parkinson's disease |
001084 |
W. G. Vincken ; C. M. Darauay ; M. G. Cosio | Reversibility of upper airway obstruction after levodopa therapy in Parkinson's disease |
001086 |
R. J. Uitti ; A. H. Rajput ; B. Rozdilsky ; M. Bickis ; T. Wollin ; W. K. Yuen | Regional metal concentrations in Parkinson1s disease, other chronic neurological diseases, and control brains |
001087 |
E. C. Wolters ; C.-C. Huang ; C. Clark ; R. F. Peppard ; J. Okada ; N.-S. Chu ; M. J. Adam ; T. J. Ruth ; D. Li ; D. B. Calne | Positron emission tomography in manganese intoxication |
001089 |
A. H. Rajput ; R. J. Uitti ; S. Sudhakar ; B. Rozdilsky | Parkinsonism and neurofibrillary tangle pathology in pigmented nuclei |
001090 |
M. Guttman ; R. S. Burns ; W. R. W. Martin ; R. F. Peppard ; M. J. Adam ; T. J. Ruth ; G. Allen ; R. A. Parker ; N. B. Tulipan ; D. B. Calne | PET studies of Parkinsonian patients treated with autologous adrenal implants |
001091 |
H. Teravainen ; J. K. C. Tsui ; E. Mak ; D. B. Calne | Optimal indices for testing parkinsonian rigidity |
001093 |
G. S. Robertson ; D. G. Herrera ; M. Dragunow ; H. A. Robertson | L-DOPA activates c-fos in the striatum ipsilateral to a 6-hydroxydopamine lesion of the substantia nigra |
001094 |
D. Riley ; A. E. Lang ; R. D. G. Blair ; A. Birnbaum ; B. Reid | Frozen shoulder and other shoulder disturbances in Parkinson's disease |
001096 |
P. J. Bedard ; R. Boucher | Effect of D1 receptor stimulation in normal and MPTP monkeys |
001097 |
C. Harnois ; G. Marcotte ; T. Di Paolo | Different sensitivities to MPTP toxicity in primate nigrostriatal and retinal dopaminergic systems: electrophysiological and biochemical evidence |
001098 |
S. M. Schnider ; R. H. Kwong ; F. A. Lenz ; H. C. Kwan | Detection of feedback in the central nervous system using system identification techniques |
001099 |
J. G. Milton ; A. Longtin ; A. Beuter ; M. C. Mackey ; L. Glass | Complex dynamics and bifurcations in neurology |
001100 |
E. C. Wolters ; T. A. Hurwitz ; R. F. Peppard ; D. B. Calne | Clozapine: an antipsychotic agent in Parkinson's disease? |
001103 |
T. A. Cox ; J. V. Mcdarby ; L. Lavine ; J. C. Steele ; D. B. Calne | A retinopathy on Guam with high prevalence in Lytico-Bodig |
001104 |
J. K. C. Tsui ; E. C. Wolters ; R. F. Peppard ; D. B. Calne | A double-blind, placebo-controlled, dose-ranging study to investigate the safety and efficacy of CY 208-243 in patients with Parkinson's disease |
001105 |
S. J. Kish ; K. Shannak ; O. Hornykiewicz | Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease: pathophysiologic and clinical implications |
001106 |
T. A. Hurwitz ; D. B. Calne ; K. Waterman | Treatment of dopaminomimetic psychosis in Parkinson's disease with electroconvulsive therapy |
001108 |
T. L. Perry ; K. Jones ; S. Hansen | Tetrahydroisoquinoline lacks dopaminergic nigrostriatal neurotoxicity in mice |
001110 |
F. A. Lenz ; R. R. Tasker ; H. C. Kwan ; S. Schnider ; R. Kwong ; Y. Murayama ; J. O. Dostrovsky ; J. T. Murphy | Single unit analysis of the human ventral thalamic nuclear group: correlation of thalamic "tremor cells" with the 3-6 Hz component of Parkinsonian tremor |
001112 |
M. Pisa | Regional specialization of motor functions in the rat striatum: implications for the treatment of parkinsonism |
001113 |
P. L. Mcgeer ; S. Itagaki ; B. E. Boyes ; E. G. Mcgeer | Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains |
001114 |
P. L. Mcgeer ; S. Itagaki ; H. Akiyama ; E. G. Mcgeer | Rate of cell death in parkinsonism indicates active neuropathological process |
001115 |
J. A. Saint-Cyr ; A. E. Taylor ; A. E. Lang | Procedural learning and neostriatal dysfunction in man |
001116 |
J. D. Grimes ; M. N. Hassan ; J. H. Thakar | Prevention of progression of Parkinson's disease with antioxidative therapy |
001117 |
D. Riley ; A. E. Lang | Practical application of a low-protein diet for Parkinson's disease |
001120 |
M. W. Rogers ; C. W. Y. Chan | Motor planning is impaired in Parkinson's disease |
001121 |
D. B. Calne ; A. J. Lees | Late progression of post encephalitic Parkinson's syndrome |
001122 |
A. E. Taylor ; J. A. Saint-Cyr ; A. E. Lang | Idiopathic Parkinson's disease: revised concepts of cognitive and affective status |
001123 |
M. N. Hassan ; J. H. Thakar | Dopamine receptors in Parkinson's disease |
001124 |
J. J. Gilbert ; S. J. Kish ; LI-JAN CHANG ; C. Morito ; K. Shannak ; O. Hornykiewicz | Dementia, parkinsonism, and motor neuron disease: neurochemical and neuropathological correlates |
001125 |
T. L. Perry ; S. Hansen ; K. Jones | Brain amino acids and glutathione in progressive supranuclear palsy |
001126 |
P. Falardeau ; S. Bouchard ; P. J. Bedard ; R. Boucher ; T. Di Paolo | Behavioral and biochemical effect of chronic treatment with D-1 and/or D-2dopamine agonists in MPTP monkeys |
001127 |
J. P. Hunter ; P. Ashby ; A. E. Lang | Afferent contributing to the exaggerated long latency reflex response to electrical stimulation in Parkinson's disease |
001128 |
R. J. Riopelle | Adrenal medulla autografts in Parkinson's disease: a proposed mechanism of action |
001129 |
M. Filion ; L. Tremblay ; P. J. Bedard | Abnormal influences of passive limb movement on the activity of globus pallidus neurons in parkinsonian monkeys |
001130 |
E. C. Wolters ; J. C. Kebabian ; M. Guttman ; E. Mak ; B. D. Pate ; D. B. Calne | A new device for the quantitative assessment of dopaminergic drug effects in unilateral MPTP-lesioned monkeys |
001131 |
T. L. Perry ; K. Jones ; S. Hansen ; R. A. Wall | 2-Phenylpyridine and 3-phenylpyridine, constituents of tea, are unlikely to cause idiopathic Parkinson's disease |
001132 |
J. H. Thakar ; M. N. Hassan ; J. D. Grimes | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), its metabolite cyperquat (MPP+) and energy transduction in mitochondria from rat striatum and liver |
001134 |
E. Keller | Mesures ultrasoniques des mouvements du dos de la langue en production de la parole: aspects cliniques |
001135 |
T. L. Perry ; VOON WEE YONG ; S. Hansen ; K. Jones ; C. Bergeron ; J. G. Foulks ; J. M. Wright | α-Tocopherol and β-carotene do not protect marmosets against the dopaminergic neurotoxicity of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine |
001137 |
M. Freedman ; M. Oscar-Berman | Tactile discrimination learning deficits in Alzheimer's and Parkinson's diseases |
001138 |
J. A. Sharpe ; W. A. Fletcher ; A. E. Lang ; D. H. Zackon | Smooth pursuit during dose-related on-off fluctuations in Parkinson's disease |
001139 |
A. A. F. Sima ; G. Hoag ; B. Rozdilsky | Shy-Drager syndrome: the transitional variant |
001142 |
A. E. Lang | Restless legs syndrome and Parkinson's disease: insights into pathophysiology |
001144 |
A. E. Taylor ; J. A. Saint-Cyr ; A. E. Lang | Parkinson's disease: cognitive changes in relation to treatment response |
001145 |
D. Regan ; C. Maxner | Orientation-selective visual loss in patients with Parkinson's disease |
001147 |
H. A. Robertson ; G. S. Robertson | Hypothesis. Combined L-dopa and bromocriptine therapy for Parkinson's disease: a proposed mechanism of action |
001148 |
S. Calne ; B. Schoenberg ; W. Martin ; R. J. Uitti ; P. Spencer ; D. B. Calne | Familial Parkinson's disease: possible role of environmental factors |
001150 |
J. Poirier ; A. Barbeau | Erythrocyte antioxidant activity in human patients with Parkinson's disease |
001153 |
J. M. Radke ; P. Cumming ; S. R. Vincent | Effects of MPTP poisoning on central somatostatin and substance P levels in the mouse |
001154 |
A. Barbeau ; M. Roy ; G. Bernier ; G. Campanella ; S. Paris | Ecogenetics of Parkinson's disease: prevalence and environmental aspects in rural areas |
001156 |
J. D. S. Mckean ; P. B. R. Allen ; L. J. Filipow ; J. D. R. Miller | CT guided functional stereotaxic surgery |
001157 |
D. Kimura ; A. Hahn ; H. J. M. Barnett | Attentional and perseverative impairment in two cases of familial fatal Parkinsonism with cortical sparing |
001158 |
A. E. Lang ; K. Johnson | Akathisia in idiopathic Parkinson's disease |
001160 |
A. H. Rajput ; K. P. Offord ; C. M. Beard ; L. T. Kurland | A case-control study of smoking habits, dementia, and other illnesses in idiopathic Parkinson's disease |
001161 |
T. L. Perry ; K. Jones ; S. Hansen ; R. A. Wall | 4-phenylpyridine and three other analogues of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine lack dopaminergic nigrostriatal neurotoxicity in mice and marmosets |
001164 |
H. Teravainen ; L. Forgach ; M. Hietanen ; M. Schulzer ; B. Schoenberg ; D. B. Calne | The age of onset of Parkinson's disease: etiological implications |
001167 |
C. B. Bozek ; O. Suchowersky ; S. Purves ; S. Calne ; D. B. Calne | Sinemet in Parkinson's disease: efficacy with and without food |
001168 |
M. Freedman ; M. Oscar-Berman | Selective delayed response deficits in Parkinson's and Alzheimer's disease |
001170 |
T. L. Perry ; VOON WEE YONG ; R. A. Wall ; K. Jones | Paraquat and two endogenous analogues of the neurotoxic substance N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine do not damage dopaminergic nigrostriatal neurons in the mouse |
001171 |
T. Di Paolo ; P. Bedard ; M. Daigle ; R. Boucher | Long-term effects of MPTP on central and peripheral catecholamine and indoleamine concentrations in monkeys |
001173 |
H. Kamo ; S. U. Kim ; P. L. Mcgeer ; D. H. Shin | Functional recovery in a rat model of Parkinson's disease following transplantation of cultured human sympathetic neurons |
001174 |
A. E. Taylor ; J. A. Saint-Cyr ; A. E. Lang | Frontal lobe dysfunction in Parkinson's disease |
001175 |
J. Kish ; A. Rajput ; J. Gilbert ; B. Rozdilsky ; L.-J. Chang ; K. Shannak ; O. Hornykiewicz | Elevated γ-aminobutyric acid level in striatal but not extrastriatal brain regions in Parkinson's disease: correlation with striatal dopamine loss |
001176 |
E. Lau ; K. Waterman ; R. Glover ; M. Schulzer ; D. B. Calne | Effect of antacid on levodopa therapy |
001177 |
A. H. Rajput ; R. J. Uitti ; W. Stern ; W. Laverty | Early onset Parkinson's disease in Saskatchewan-environmental considerations for etiology |
001180 |
C. W. Y. Chan | Could parkinsonian akinesia be attributable to a disturbance in the motor preparatory process? |
001184 |
P. J. Bedard ; T. Di Paolo ; P. Falardeau ; R. Boucher | Chronic treatment with L-DOPA, but not bromocriptine induces dyskinesia in MPTP-Parkinsonian monkeys. Correlation with [3H]spiperone binding |
001185 |
D. B. Calne ; E. Mcgeer ; A. Eisen ; P. Spencer | Alzheimer's disease, Parkinson's disease, and motoneurone disease: abiotropic interaction between ageing and environment? |
001186 |
W. R. W. Martin | Positron emission tomography in movement disorders |
001187 |
K. S. Polyzoidis ; J. D. Mc Queen ; A. H. Rajput ; D. J. Mac Fadyen | Parkinsonism as a manifestation of brain tumor |
001188 |
R. J. Uitti ; A. H. Rajput ; E. M. Ashenhurst ; B. Rozdilsky | Cyanide-induced parkinsonism: a clinicopathologic report |
001189 |
C. J. Gibson ; M. Logue ; J. H. Growdon | CSF monoamine metabolite levels in Alzheimer's and Parkinson's disease |
001192 |
D. Regan ; D. Neima | Visual fatigue and visual evoked potentials in multiple sclerosis, glaucoma, ocular hypertension and Parkinson's disease |
001194 |
D. Regan ; D. Neima | Low-contrast letter charts in early diabetic retinopaphy, ocular hypertension, glaucoma, and Parkinson's disease |
001195 |
A. H. Rajput ; K. P. Offord ; C. M. Beard ; L. T. Kurland | Epidemiology of Parkinsonism: incidence, classification, and mortality |
001197 |
W. G. Tatton ; W. Bedingham ; M. C. Verrier ; R. D. G. Blair | Characteristic alterations in responses to imposed wrist displacements in parkinsonian rigidity and dystonia musculorum deformans |